Spectroscan brings the licence of their patent on the CRS for « health applications » in exclusivity, for 49% of Animascope. All the Spectroscan’s employees join Animascope, while Spectroscan continues to adress its historial market on Non Destructive Analysis.

SPECTROSCAN has developped a proprietary method based on Computational Tomography together with a dedicated machine named Contrôle Radiosynthétique (CRS) protected by an european patent with a lot of application in medical imaging, safety and industrial controls on line.